Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor update. The change does not affect public content or functionality.
    Difference
    0.0%
    Check dated 2026-06-08T23:08:19.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now includes the disease name 'Multiple myeloma' in its topics and adds 'MedlinePlus Genetics' as a related topic, enhancing navigation to disease context and educational resources.
    Difference
    0.1%
    Check dated 2026-05-25T16:46:10.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated to v3.5.4, replacing the prior version. This appears to be a maintenance/formatting update rather than a change to substantive study information.
    Difference
    0.0%
    Check dated 2026-05-18T13:23:26.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The related topics block no longer lists 'Multiple myeloma' or provides a link to 'MedlinePlus Genetics,' and the related topics header is removed.
    Difference
    0.1%
    Check dated 2026-05-11T12:00:46.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Adds related topic metadata to the study page, including the term 'Multiple myeloma' and a 'MedlinePlus Genetics' entry under related topics. This surfaces disease-specific and genetics resources to aid navigation and context.
    Difference
    0.1%
    Check dated 2026-05-04T08:08:56.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The record’s administrative details were refreshed, including updated last-update dates, revision/version information, and an updated EU trial identifier. The listed number and geographic distribution of participating locations were also adjusted (with some sites removed and new/updated site entries added).
    Difference
    4%
    Check dated 2026-04-27T07:43:19.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.